Literature DB >> 2068075

Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.

W J Storkus1, R D Salter, J Alexander, F E Ward, R E Ruiz, P Cresswell, J R Dawson.   

Abstract

Structural characteristics of major histocompatibility complex class I antigens associated with natural killer (NK)-resistance phenomena were examined. Previous research has shown that transfection of class I genomic DNA clones into class I-deficient, NK-sensitive target cell lines results in transfectants exhibiting class I+, NK-resistant phenotypes. In contrast to the HLA-A3, -B7, -B27, and -Bw58 class I molecules, the HLA-A2 class I molecules were shown not to protect target cells from NK activity. Here we show that this nonprotective phenotype maps to the alpha 1 domain of the HLA-A2 molecule by examining the NK-protective capacity of the natural interdomain recombinant HLA-Aw69 molecule. HLA-Aw69, which consists of an alpha 1 domain exhibiting homology with HLA-Aw68, and alpha 2/alpha 3/transmembrane-cytoplasmic domains, exhibiting homologies with HLA-A2, mimics HLA-Aw68 and provides HLA-A,B null target cell (C1R) transfectants with increased resistance to NK. Further, the inability of transfected HLA-A2 to confer protection against NK activity can be completely attributed to the expression of a "nonpermissive" residue at position 74 in the alpha 1 domain. Site-directed mutation of the His-74 residue in HLA-A2 to the Asp-74 (HLA-A3, -Aw68, -Aw69, -B7) residue generates a mutant that provides C1R cell line transfectants an NK-resistant phenotype. As His-74 blocks access to a side pocket in the HLA-A2 antigen-binding cleft, these results support the critical involvement of residues within the peptide-binding groove of class I molecules in determining the NK susceptibility phenotype of class I+ target cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068075      PMCID: PMC52007          DOI: 10.1073/pnas.88.14.5989

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules.

Authors:  W J Storkus; J R Dawson
Journal:  Crit Rev Immunol       Date:  1991       Impact factor: 2.214

Review 2.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

3.  Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: studies employing recombinants within the H-2 complex.

Authors:  L R Gooding
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

4.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

Review 5.  Heterogeneity of natural killer cells.

Authors:  J R Ortaldo; R B Herberman
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

6.  Assembly and maturation of HLA-A and HLA-B antigens in vivo.

Authors:  M S Krangel; H T Orr; J L Strominger
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

7.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.

Authors:  B Sugden; K Marsh; J Yates
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

8.  Effect of vesicular stomatitis virus infection on the histocompatibility antigen of L cells.

Authors:  T T Hecht; D F Summers
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

9.  Abrogation of hematogenous metastases in a murine model by natural killer cells.

Authors:  J P Richie
Journal:  Surgery       Date:  1984-08       Impact factor: 3.982

Review 10.  Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function.

Authors:  P C Doherty; B B Knowles; P J Wettstein
Journal:  Adv Cancer Res       Date:  1984       Impact factor: 6.242

View more
  42 in total

1.  Alloreactivity and association of human natural killer cells with the major histocompatibility complex.

Authors:  E Mavoungou; A Sall; V Poaty-Mavoungou; F S Toure; P Yaba; A Delicat; J Lansoud-Soukate
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  Histocompatibility antigens and natural killer susceptibility.

Authors:  J Peña; R Solana
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

3.  Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.

Authors:  F Zappacosta; F Borrego; A G Brooks; K C Parker; J E Coligan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-09-09       Impact factor: 5.422

5.  Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis.

Authors:  O Ayalon; E A Hughes; P Cresswell; J Lee; L O'Donnell; R Pardi; J R Bender
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

6.  The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand.

Authors:  M Orihuela; D H Margulies; W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 7.  Natural killer cell receptors specific for major histocompatibility complex class I molecules.

Authors:  W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

Review 8.  Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells.

Authors:  R R Brutkiewicz; R M Welsh
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses.

Authors:  W M Liu; D W Fowler; P Smith; A G Dalgleish
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

Review 10.  Re-educating natural killer cells.

Authors:  Joseph C Sun
Journal:  J Exp Med       Date:  2010-09-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.